Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’m curious why no new trials started yet
Man….even when there’s nothing to discuss, it’s the same ol people pumping/dumping the same ol bs.
So nice to live life outside of this board.
When there’s new info the company releases, the o.g. Posters come out of hibernation. Until then….
All the complaints lately about Missling news this and news that.
Let’s have a hypothetical situation where you go ahead and rid yourselves of Anavex stock.
Where oh where would you reinvest your money?
Seems like with all the complaints about the sp, there’s no better gamble than Anavex right now.
And when that data comes and goes yet we still are here in the teens….then what? I don’t care if Missling keeps data from the public, because data people don’t understand does nothing. Look at how all past data did and question yourself how the next data release will be different. As long as he or enough to know alls well that ends well…..is something I’d be fine with.
Why? Cause I’m not interested in the $20s or $40s
It’s those triple digits.
Of course we are getting there.
Who WE are depends.
Probably won’t be those begging for data right now
What part of TL met all endpoints you don’t understand?
Can’t PR that and release full data later that proves something else.
Re-read the filings.
He sold 1/2 to keep the other 1/2
Could you provide any spec of proof as to why it wouldn’t? Given how one p3 already read out?
Missling delaying and slow walking is not an option
Wow. Can’t attack the science so this is the best that can be done…..
Can’t trust Missling because what happened to another co.
Sticky worthy
I’m sure Gottlieb moved on from being lead person from the FDA cause he was tired as well….. sarcastic laugh. He knew BP would tirelessly try and get things approved. If ya can’t beat ‘em, join em.
Become a millionaire in the process
You understand that every p2 p2/3 trial met primary and secondary endpoints right?
Saying otherwise is down right comedic
As much as I’d love to believe that, was it really a coincidence the extended adult Rett data was released a few days before options were exercised?
As long as they continue to be positive is all that matter to me. The longer we stay beaten down, the more accumulation is possible.
Yes, I do add a few here and there as funds allow it.
Say Anavex DOES get Blarcamesine approved for Rett, then AD….how could a price tag be put on a buyout when A-371 is waiting for its turn to shine. If Sigmar1 gets the respect Amalyoid did, Anavex is in perfect position to be most envied.
Doesn’t seem like a buyout is what’s desired.
Which then brings us to where the SP is. Ignore.
The co was literally months away from bankruptcy before Missling was hired.
Thanks to whomever it was that posted that 2013 tidbit.
I THINK CTAD 2023 IN OCTOBER, the kraken will be released.
Come on now, SP doesn’t relate to how much a company is worth. It’s what the STREET wants you to think it’s worth.
Is SAVA really a better co than AVXL?
It’s happened many times over the years. This co has the next AD drug, that co has the next one. They all got pumped right into failed trials.
What an odd number to sell. Might as well have sold 273.
The good thing is that he stayed for 10 years to be awarded that option.
You know if there’s any further rewards down the road.
More in x years, if something goes to market
Same reasoning for naked shorting the ticker. Definitely worth the slap on the wrist to keep the sp suppressed.
How? It’s the easier of the two trials
Hard level vs easy….
Maybe that’s something that’s being discussed…..
Or not.
Shouldn’t take too long to figure out the baseline mg needed, per patient, to be within a range…..
Precision medicine. Up to 50mg Blarcamesine to maintain __ percent blood concentration. Each person requiring different mg to hit that mark across all indications.
It’s that simple.
That’s the holdup
I’d agree in that it’s the blood concentration vice amount of drug taken.
“By going the AA route, they
would need to initiate a confirmatory
trial per AA protocol. So all hands on
deck for AD trial? And all hands on
deck for RETT approval. That's my
guess.”
Imagine the rest of any trial for A-273 being confirmatory trials.
- Epilepsy
- “Undisclosed”, for I don’t know, 3 years already?
- and
- and
- and
Quickly appreciating as “the street” finally acknowledges the eye widening potential of this “ magic pill”
What’s faster to towards sales?
Going the AA route, knowing that it meets or surpasses the 2 recently approved therapies?
Or…
Using your newly discovered biomarker and trying to convince everyone that it is a better target than clearing out Plaques?
They had two options. Traditional approval or AA.
The FDA already AA two other therapies, giving Anavex the map on what it’ll take to get there.
Heck, all Anavex has to do it show that they can hit that same mark, and it’ll be AA on mild side effects alone.
Let’s see how this post ages.
Don’t forget depression, insomnia, and seizures too
Come on now. How many top line results did he already mention met primary and secondary?
The goods is there, just be patient like a dubstep song and wait for the drop.
I’m interested in your thinking of the company having an anti takeover pill.
100,000,000 extra shares is a drop in the bucket compared to the potential sales of Blarcamesine per year.
If a slice of the pie is x amount, why not just be aggressive and take the whole pie if it’s THAT good.
Wasn’t Rett adult p3 trial already done and PR’d?
All primary and secondary endpoints met.
Just waiting on the pediatric P3 results?
Wasnt Biogen first approval based off of a p2 trial ONLY?
Same as their second approval?
Curious how exactly would he have upset said BP companies?
Giving them real statistics of a trial and they didn’t like the result?
He’s probably the most credible person working for Anavex right now.
I’m sure he’s having to also navigate the potential of being hostilely taken over.
There’s no poison pill poisonous enough, right now, if Anavex has the goods to be approved for all the above.
I bet we get the data and partner announcement on the same day
How about by summer of 24 Blarcamesine will be approved and pps will be over $80
Sure glad I can laugh at amateur conclusions.
Reminds me of that line from Tommy Boy
Exactly. Once revenue starts flowing…..Anavex will be taken A LOT more seriously.
I’d replace most with all to date. Even those currently approved, fail in the long run.